164 related articles for article (PubMed ID: 38201813)
1. Mucoadhesive Hybrid System of Silk Fibroin Nanoparticles and Thermosensitive In Situ Hydrogel for Amphotericin B Delivery: A Potential Option for Fungal Keratitis Treatment.
Chomchalao P; Saelim N; Lamlertthon S; Sisopa P; Tiyaboonchai W
Polymers (Basel); 2024 Jan; 16(1):. PubMed ID: 38201813
[TBL] [Abstract][Full Text] [Related]
2. Solid Dispersion Incorporated into Dissolving Microneedles for Improved Antifungal Activity of Amphotericin B:
Mahfud MAS; Syahirah NA; Akram M; Mahfufah U; Saputra MD; Elim D; Andi MNF; Sultan NAF; Himawan A; Domínguez-Robles J; Pamornpathomkul B; Mir M; Permana AD
Mol Pharm; 2023 Dec; 20(12):6246-6261. PubMed ID: 37975721
[TBL] [Abstract][Full Text] [Related]
3. Ocular amphotericin B delivery by chitosan-modified nanostructured lipid carriers for fungal keratitis-targeted therapy.
Fu T; Yi J; Lv S; Zhang B
J Liposome Res; 2017 Sep; 27(3):228-233. PubMed ID: 27601177
[TBL] [Abstract][Full Text] [Related]
4. Development of thermosensitive hydrogel of Amphotericin-B and Lactoferrin combination-loaded PLGA-PEG-PEI nanoparticles for potential eradication of ocular fungal infections:
Elhabal SF; Ghaffar SA; Hager R; Elzohairy NA; Khalifa MM; Mohie PM; Gad RA; Omar NN; Elkomy MH; Khasawneh MA; Abdelaal N
Int J Pharm X; 2023 Dec; 5():100174. PubMed ID: 36908304
[TBL] [Abstract][Full Text] [Related]
5. Amphotericin B containing microneedle ocular patch for effective treatment of fungal keratitis.
Roy G; Galigama RD; Thorat VS; Mallela LS; Roy S; Garg P; Venuganti VVK
Int J Pharm; 2019 Dec; 572():118808. PubMed ID: 31678387
[TBL] [Abstract][Full Text] [Related]
6. Self-aggregated nanoparticles based on amphiphilic poly(lactic acid)-grafted-chitosan copolymer for ocular delivery of amphotericin B.
Zhou W; Wang Y; Jian J; Song S
Int J Nanomedicine; 2013; 8():3715-28. PubMed ID: 24106427
[TBL] [Abstract][Full Text] [Related]
7. Optimization, stabilization, and characterization of amphotericin B loaded nanostructured lipid carriers for ocular drug delivery.
Lakhani P; Patil A; Wu KW; Sweeney C; Tripathi S; Avula B; Taskar P; Khan S; Majumdar S
Int J Pharm; 2019 Dec; 572():118771. PubMed ID: 31669555
[TBL] [Abstract][Full Text] [Related]
8. Thermosensitive Tri-Block Polymer Nanoparticle-Hydrogel Composites as Payloads of Natamycin for Antifungal Therapy Against
Sha X; Chan L; Fan X; Guo P; Chen T; Liu L; Zhong J
Int J Nanomedicine; 2022; 17():1463-1478. PubMed ID: 35378880
[TBL] [Abstract][Full Text] [Related]
9. Oral administration of amphotericin B nanoparticles: antifungal activity, bioavailability and toxicity in rats.
Radwan MA; AlQuadeib BT; Šiller L; Wright MC; Horrocks B
Drug Deliv; 2017 Nov; 24(1):40-50. PubMed ID: 28155565
[TBL] [Abstract][Full Text] [Related]
10. Assessment of in vitro antifungal efficacy and in vivo toxicity of Amphotericin B-loaded PLGA and PLGA-PEG blend nanoparticles.
Moraes Moreira Carraro TC; Altmeyer C; Maissar Khalil N; Mara Mainardes R
J Mycol Med; 2017 Dec; 27(4):519-529. PubMed ID: 28797532
[TBL] [Abstract][Full Text] [Related]
11. Amphotericin B nanohydrogel ocular formulation using alkyl glyceryl hyaluronic acid: Formulation, characterization, and in vitro evaluation.
Banshoya K; Fujita C; Hokimoto Y; Ohnishi M; Inoue A; Tanaka T; Kaneo Y
Int J Pharm; 2021 Dec; 610():121061. PubMed ID: 34481008
[TBL] [Abstract][Full Text] [Related]
12. Thermosensitive and mucoadhesive in situ ocular gel for effective local delivery and antifungal activity of itraconazole nanocrystal in the treatment of fungal keratitis.
Permana AD; Utami RN; Layadi P; Himawan A; Juniarti N; Anjani QK; Utomo E; Mardikasari SA; Arjuna A; Donnelly RF
Int J Pharm; 2021 Jun; 602():120623. PubMed ID: 33892058
[TBL] [Abstract][Full Text] [Related]
13. Supramolecular Chitosan Micro-Platelets Synergistically Enhance Anti-Candida albicans Activity of Amphotericin B Using an Immunocompetent Murine Model.
Grisin T; Bories C; Bombardi M; Loiseau PM; Rouffiac V; Solgadi A; Mallet JM; Ponchel G; Bouchemal K
Pharm Res; 2017 May; 34(5):1067-1082. PubMed ID: 28168390
[TBL] [Abstract][Full Text] [Related]
14. Amphotericin B Polymer Nanoparticles Show Efficacy against
Alakkad A; Stapleton P; Schlosser C; Murdan S; Odunze U; Schatzlein A; Uchegbu IF
Pathogens; 2022 Jan; 11(1):. PubMed ID: 35056021
[TBL] [Abstract][Full Text] [Related]
15. Amphotericin B loaded ethyl cellulose nanoparticles with magnified oral bioavailability for safe and effective treatment of fungal infection.
Kaur K; Kumar P; Kush P
Biomed Pharmacother; 2020 Aug; 128():110297. PubMed ID: 32480227
[TBL] [Abstract][Full Text] [Related]
16. A novel formulation of solubilised amphotericin B designed for ophthalmic use.
Serrano DR; Ruiz-Saldaña HK; Molero G; Ballesteros MP; Torrado JJ
Int J Pharm; 2012 Nov; 437(1-2):80-2. PubMed ID: 22890190
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Liposomal and Conventional Amphotericin B in Experimental Fungal Keratitis Rabbit Model.
Ghosh AK; Rudramurthy SM; Gupta A; Choudhary H; Singh S; Thakur A; Jatana M
Transl Vis Sci Technol; 2019 May; 8(3):35. PubMed ID: 31205812
[TBL] [Abstract][Full Text] [Related]
18.
Liu F; Yang L; Li Y; Junier A; Ma F; Chen J; Han H; Glass Z; Zhao X; Kumamoto CA; Sang H; Xu Q
ACS Biomater Sci Eng; 2020 Feb; 6(2):1064-1073. PubMed ID: 33464849
[TBL] [Abstract][Full Text] [Related]
19. Biodegradable functional polycarbonate micelles for controlled release of amphotericin B.
Wang Y; Ke X; Voo ZX; Yap SSL; Yang C; Gao S; Liu S; Venkataraman S; Obuobi SAO; Khara JS; Yang YY; Ee PLR
Acta Biomater; 2016 Dec; 46():211-220. PubMed ID: 27686042
[TBL] [Abstract][Full Text] [Related]
20. Enhanced antifungal effects of amphotericin B-TPGS-b-(PCL-ran-PGA) nanoparticles in vitro and in vivo.
Tang X; Zhu H; Sun L; Hou W; Cai S; Zhang R; Liu F
Int J Nanomedicine; 2014; 9():5403-13. PubMed ID: 25473279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]